🔎 Trials Near Me

Gara Jalqabaatti › Kansaar Onnee Triple-Negative › California › San Diego

Qorannoo klinikaalii Kansaar Onnee Triple-Negative San Diego, CA keessatti

Qorannoo 13 Kansaar Onnee Triple-Negative f San Diego fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of California San Diego, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT04981119

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Namoota walitti qabaa jiraSadarkaa 3
  • Scripps Cancer Center ( Site 0052), La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06393374

Intratumoral N17350 in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Scripps Clinic Torrey Pines - La Jolla, San Diego
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07339176

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06400472

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07029399

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of California, San Diego; Moores Cancer Center, San Diego
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT05579366

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • University of California San Diego, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT01042379

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

Namoota walitti qabaa jiraSadarkaa 1
  • UCSD Moores Cancer Center, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT06908928

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Namoota walitti qabaa jiraSadarkaa 1/2
  • UCSD Moores Cancer Center, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT06682793

A Beta-only IL-2 ImmunoTherapY Study

Namoota walitti qabaa jiraSadarkaa 1/2
  • Sharp Memorial Hospital, San Diego
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ado-2025 · NCT05086692

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Gur-2024 · NCT04282044

Qorannoo Kansaar Onnee Triple-Negative magaalota biroo keessatti

Qorannoo biroo San Diego keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.